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Abstract
Background: Statistical comparison of peptide profiles in biomarker discovery requires fast, user-
friendly software for high throughput data analysis. Important features are flexibility in changing
input variables and statistical analysis of peptides that are differentially expressed between patient
and control groups. In addition, integration the mass spectrometry data with the results of other
experiments, such as microarray analysis, and information from other databases requires a central
storage of the profile matrix, where protein id's can be added to peptide masses of interest.
Results: A new database application is presented, to detect and identify significantly differentially
expressed peptides in peptide profiles obtained from body fluids of patient and control groups. The
presented modular software is capable of central storage of mass spectra and results in fast analysis.
The software architecture consists of 4 pillars, 1) a Graphical User Interface written in Java, 2) a
MySQL database, which contains all metadata, such as experiment numbers and sample codes, 3)
a FTP (File Transport Protocol) server to store all raw mass spectrometry files and processed data,
and 4) the software package R, which is used for modular statistical calculations, such as the
Wilcoxon-Mann-Whitney rank sum test. Statistic analysis by the Wilcoxon-Mann-Whitney test in
R demonstrates that peptide-profiles of two patient groups 1) breast cancer patients with
leptomeningeal metastases and 2) prostate cancer patients in end stage disease can be distinguished
from those of control groups.
Conclusion: The database application is capable to distinguish patient Matrix Assisted Laser
Desorption Ionization (MALDI-TOF) peptide profiles from control groups using large size datasets.
The modular architecture of the application makes it possible to adapt the application to handle
also large sized data from MS/MS- and Fourier Transform Ion Cyclotron Resonance (FT-ICR) mass
spectrometry experiments. It is expected that the higher resolution and mass accuracy of the FT-
ICR mass spectrometry prevents the clustering of peaks of different peptides and allows the
identification of differentially expressed proteins from the peptide profiles.
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In mass spectrometry (MS), analysis of mass spectra is
possible with various software packages. In general these
software applications work fine for the analysis of individ-
ual spectra, but lack the ability to compare very large
number of spectra and address differences in (peptide)
profile masses to certain groups, such as patient and con-
trol groups. Therefore, it is necessary to have fast, user-
friendly software for high throughput data pre processing,
flexibility in changing input variables and statistical tools
to analyze the peptides that are significantly differentially
expressed between the patient and control groups. Statis-
tical calculations are performed within seconds to at most
several hours. To the best of our knowledge the only open
source project that is capable of peptide profiling with raw
MS fid (free induction decay) files (Bruker Daltonics, Ger-
many) is the RProteomics 3-tier architecture of the Cancer
Biomedical Informatics Grid, presented in a concurrent
versions system (cabigcvs.nci.nih.gov). In the RProteom-
ics project, the main development language is R and the
application has a web interface. This paper describes an
application where MS data preprocessing is expanded
with a kind of Laboratory Information Management Sys-
tems (LIMS). It requires no grid architecture, can even be
installed on a stand-alone computer, and due to local file
interfaces can easily be integrated with commercial statis-
tical software packages visualization applications, such as
Spotfire™ [1] and Omniviz™. The presented software
architecture is capable of central storage of mass spectra
and analysis results. A central database holds all meta-
data. Meta-data consist of the origin of the measured sam-
ples, experiments performed on different mass spectrom-
eters and allocation of samples to different groups. Meta-
data can also link the experimental results to clinical
information. Information from the database can be
retrieved with Structured Query Language (SQL) and can
be linked to other databases on common keys, such as
patient code. In this study, the application is built in fast
Java code, which provides an excellent GUI, and statistic R
routines are called if needed. In addition, the protein ori-
gin of the significant peptide masses can be identified by
comparing the centrally stored peptide masses of interest
with those calculated from the human mass spectrometry
protein sequence database (for example MSDB) or by
mass spectrometry assisted sequencing. Both identifica-
tion techniques use the Mascot™ search engine [2]. The
platform independent software architecture is tested on
two sets of data: 1) Mass spectrometry (MS) files of cere-
brospinal fluid (CSF) samples from patients with breast
cancer, breast cancer with leptomeningeal metastasis
(LM) and a control group [3]; and 2) MS files of serum
samples from patients with prostate cancer in end stage
disease and a control group.
Implementation
CSF samples of breast cancer patients
The processing of the CSF samples and measurement pro-
cedures have been described before [3,4]. In brief, each
sample is processed twice, spotted 3 times on the anchor
chip™ and measured three times on the mass spectrome-
ter, which gives an average of 18 replicate spectra for each
sample. Some measurements result in so called "zero" raw
fid files with no data and a file size smaller than 5 Kbytes.
This causes replicate numbers < 18. A (dataset dependent)
replicate number of at least 7 spectra for each sample is
proposed for robust statistic comparison between the
groups [4]. The replicate number of 7 spectra for each
sample is smaller than the total replicate number of 18,
since some spectra cannot be internally calibrated on at
least 4 of the 5 omnipresent albumin peptide masses.
However, 7 replicate spectra are sufficient to find all pos-
sible peptide masses in all spectra [4]. A profile matrix is
created, which consists of peptide masses in all spectra of
the samples in the columns against the number of occur-
rences of these masses in replicate spectra of the samples
in the rows. The matrix is created with the total number of
151 samples, control, breast cancer and breast cancer with
LM and an arbitrary level of 450 peak masses for noise
spectra, and peptide masses are selected between 800 and
4000 Da. The noise threshold of 450 peak masses in a
spectrum can be varied in the database application. Peaks
with masses smaller than 800 Da are left out because they
may be attributed to matrix fragments. The replicate num-
bers of samples can be varied between 1 and 18. Table 1
gives an example of a quality report of the software, when
a profile matrix is created. This quality report is automati-
cally generated by the software architecture and stored as
a text file, with an example of the name
0.98_1_ALBMASSES(4)_sample4_binary2_quality.txt, in
the windows document root of the client workstation. In
this name 98 represents the quantile percentage, 1 is the
experiment number, ALBMASSES(4) is the name of the
mass list, used for internal calibration, 4 in sample4 the
number of chosen replicate spectra for one sample, which
can be varied between 1 and 18 and 2 the threshold of the
binary matrix table, as will be explained later. The win-
dows documents root of the client workstation is C:\Doc-
uments and Settings\username\.
Serum samples of prostate cancer patients
About 7 ml blood from 27 patients and 27 controls are
collected in clotting tubes and stored at room temperature
for a period of 2 h. Subsequently, the tubes are centrifuged
at 1000 rpm for a period of 10 minutes, and the superna-
tant is collected and stored at a temperature of -80°C. The
serum is tryptic digested and incubated overnight at a
temperature of 37°C with a 1:10 ratio with a Promega
Trypsin Gold stock solution, with a concentration of 100
μg/ml. In total 5 μl of the digested sample is bound toPage 2 of 16
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10 μl of 50% acetonitrile in Milli-Q water. An amount of
0.5 μl of the eluted fraction is spotted 4 times on the
anchor chip and measured on an Ultraflex™ MALDI-TOF
(Bruker Daltonics, Germany) in reflection mode, which
gives 4 replicate spectra for each sample. The mass spectra
internally calibrated on at least 4 of the 5 omnipresent
peptide masses, which are different from those of the CSF
experiment. A somewhat higher noise threshold than in
the CSF samples is chosen of 600 peaks in a spectrum.
Software architecture, packages and interfacing
The MS analysis software architecture consists of 4 pillars,
a Graphical User Interface (GUI) written in Java™ [28], a
MySQL™ database [5], which contains all metadata, such
as experiment numbers and sample codes, and a FTP (File
Transport Protocol) server to store all raw MS fid files and
processed data and fourth R. The software package R is
used for statistical calculations [6]. Figure 1 gives a sche-
matic overview of the architecture. The Java software com-
ponents are developed and tested on the Eclipse™
platform [7]. The raw MS fid files can manually be
selected by the Java GUI on the client and stored on a cen-
tral FTP server. For calculations, the Java client retrieves
the information in these files again. After processing of the
data, the results of analysis are transported to the FTP
server again. The FTP file storage is installed on a central
server, and the information can be retrieved by different
Java client workstations. However, for testing, the FTP
service and MySQL database are both installed on the cli-
ent workstation, with hostname localhost. Special Java
archives (Jar's) have to be in the Java Virtual Machine's
class path. The edtftpj-1.4.8.jar [8] provides an interface
for programming the standard FTP commands in Java.
The Java Database Connectivity (JDBC) driver mysql-con-
nector-Java-3.1.6-bin.jar [5] gives an interface for SQL
Table 1: Quality report. An example of a quality report, generated by the software, when a profile matrix is created.
Experimentid: 1
experimentname : cerebrospinal fluid tryptic peptide profiles to diagnose leptomeningeal metastasis in breast cancer patients
Find maxima within distance (Da) : 0.50
Quantile threshold peak finding : 0.98
Combine peaks within distance (Da) : 0.50
Noisy spectra contain peak numbers > : 450
Maximum mass spectra per sample : 4
threshold binary table 0 < 1 > = : 2
Minimum mass (Da) : 800
Maximum mass (Da) : 4000
Calibration : yes
ALBMASSES(4)
number of masses in matrix : 1949
group : control group without breast cancer(group1_control)
total number of samples : 45
number of samples in matrix : 32
number of samples with too low number of replicates : 12
number of samples not in matrix that because all spectra cannot not be calibrated or are all too noisy : 1
(total number of 6 sample(s) with at least one noisy spectrum)
group : breast cancer without leptomeningeal metastasis(group2_breast_cancer)
total number of samples : 52
number of samples in matrix : 39
number of samples with too low number of replicates : 13
number of samples not in matrix that because all spectra cannot not be calibrated or are all too noisy : 0
(total number of 5 sample(s) with at least one noisy spectrum)
group : breast cancer with leptomeningeal metastasis(group3_leptomeningeal_metastasis)
total number of samples : 54
number of samples in matrix : 40
number of samples with too low number of replicates : 12
number of samples not in matrix that because all spectra cannot not be calibrated or are all too noisy : 2
(total number of 8 sample(s) with at least one noisy spectrum)
The profile matrix consists of peptide masses in all spectra of the samples on the columns against the number of occurrences of these masses in 
replicate spectra of the samples on the rows. The software stores the contents of the quality report as a text file, e.g. with the name 
0.98_1_ALBMASSES(4)_sample4_binary2_quality.txt in the windows document root of the client workstation, namely in C:\Documents and 
Settings\username}\.Page 3 of 16
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between the Java client and the MySQL database or FTP
service is established. There are several ways to set up an
interface between Java and the statistical software package
R [10]. Java's Runtime.exec() command is used in the
database application. The advantage of applying this
method is that it requires no other adaptations than a
default installation of R. Lemkin et al[11] implemented
the method in the Micro Array Explorer project. The Runt-
ime.exec() command in Java can execute a Windows™
cmd.exe (command interpreter) batch file. The batch file,
Rterm.bat, subsequently starts an Rterm™ process. The
Rterm process has a file-based communication with Java
(Figure 1). The Java client generates all R scripts and R
input files. The name and path of the input and output
files are defined in the generated R script. Java waits until
Rterm has finished the job, and reads the output file(s).
The Java application warns if Rterm is not installed in the
default installation path on the client workstation.
Database design
Figure 2 depicts the entity relationship diagram (ERD) of
the MySQL database. The plot is created with
dbdesigner4, a visual database designer for MySQL [12].
The database is kept at minimum size. The ERD distin-
guishes two sets of tables or entities. One set contains
records with metadata of the MS measurements, namely
equipment, experiment, result, sample, group_, person,
material and origin. The other set consists of system
tables. The records of the table result contain pointers to
the MS files on the FTP server. These pointers are the
filenames in the fields of these records, which hold also
information about MALDI target plate spot positions.
Each sample generates one or more mass spectra. There-
fore, records in the table result keep the foreign key of the
sample records. The database application selects the repli-
cate spectra of each sample in order of the ascending
resultid value of the result table. The reversed selection of
replicate spectra is also studied by changing the order in
descending resultid value of the result table. The samples
have to be allocated to a certain group; control, breast can-
cer, or breast cancer with LM. The foreign key of the table
group_ in the table result achieves indirectly a link
between sample and group_. There is no direct link
between the table sample and group_. In this way, sam-
ples can be allocated to different groups in different exper-
iments. This gives more flexibility to the application, and
avoids storage of redundant sample information. Infor-
mation about the origin of a sample, for example lumbar
puncture, can be stored in a table, as well as information
about the material, CSF. A patient-id in records of the
table person can link the MS results with other clinical
data. Figure 2 shows also the second set of system support-
ing tables. These tables are named systemcode, systemcode-
item, itemvalue, and unit. The mass spectra can be
internally calibrated with five omnipresent albumin peaks
in CSF with a mass over charge (m/z) of 960.5631,
1000.6043, 1149.6156, 1511.8433 and 2045.0959Da
[13,14]. These masses are stored in records of the table
itemvalue. The series of these five calibration masses are
named Albumin Masses in a record of the table systemco-
deitem. The table systemcode offers the possibility to store
more series of internal calibration masses than Albumin
Masses in the system. The prostate cancer samples are
internally calibrated with a different set of Albumin
masses seen in most of the spectra, namely 1296.6594,
1511.7358, 1623.6973, 1639.8218, and 2044.9620Da.
GUI components and functions
The software architecture contains the following GUI
components and functions: 1) Import of the MS files from
the (local) file system and to transport of these files to the
FTP server; 2) search and selection of table records; 3) a
screen to update or insert the records; 4) allocation the
samples in different groups; 5) creating the profile matrix;
and 6) performing the Wilcoxon-Mann-Whitney rank
sum test on matrix values [15-17]. The GUI to select and
import MS file to the FTP server is based on the Java's JFi-
leChooser Class [9]. JFileChooser is a member of the
Swing™ library for the GUI design. Most GUI components
where build with this toolkit to keep the same look and
feel throughout the application (except for the ugly JText-
System architectureFigure 1
System architecture. The system architecture consists of 
a client JAVA code for fast processing of data while a MySQL 
database on the server contains all the MS metadata. An FTP 
service puts all the raw files and processed data on the 
server and client R is used for statistical analysis.Page 4 of 16
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these purposes, like the (SWT based) Eclipse IDE for
development. One or more file(s) or even complete direc-
tories can be selected, and all files including subdirecto-
ries are transported to the FTP server location /ftp_root/
year/experimentnumber, for example C:\Inetpub\ftp-
root\2005\1\group2_f_2CSF20_0_B20_1SRef_fid. The
combination of file type and the type of instrument deter-
mines how the data in the files should be processed. File
types that can be imported into the system are at present
binary fid and text files in ASCII format (American Stand-
ard Code for Information Interchange). This can be
extended with any other file type. If the file type is fid,
Bruker related acqu and acqus files, containing the cali-
bration constants are also transported to the FTP server.
The calibration constants have a totally different meaning
for data measured with the TOF or FT-ICR technique.
When the mass spectra are imported into the system,
result records are created in the database. Each record of
the table result refers to each mass spectrum, which is
measured for a certain sample. For statistical analysis of
the data, these result records have to be linked to samples
and samples have to be placed in groups. The allocation
module achieves this by constructing a link between the
records of the result and sample table, and the result and
group_ table, respectively (Figure 3). The field filename in
a record of the result table holds the spot position the
anchor chip, because it is part of the filename. Records in
the table sample and table group_ hold the sample and
group codes in their table fields. Table maintenance
screens can add additional sample information, such as
person, material, and origin. The matrix of number of
occurrences of mass peaks in replicates of different sam-
ples allocated to different groups is created in another
Entity relationship diagram (ERD)Figure 2
Entity relationship diagram (ERD). Entity relationship diagram (ERD) of the MySQL proteomics database. The plot is cre-
ated with dbdesigner4, a visual database designer for MySQL [12].Page 5 of 16
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simultaneously, one with the number of occurrences of
masses in replicate spectra of different samples, a binary
table with number of occurrences of masses above a spe-
cific threshold, and finally a matrix with the mean inten-
sity of the present peaks in the mass spectra replicates.
Figure 4 on bottom shows only a small fraction of a matrix
with a total of 1949 peptide masses from 111 matrix sam-
ples, where the numbers of occurrences of the peptide
masses in 4 replicate spectra of 5 matrix samples are visi-
ble. An example is the peptide mass of 804.46 Da, which
is measured in a frequency of 2, 0, 0, 2 and 3 times for the
5 samples with code CSF17, CSF100, CSF101, CSF108,
and CSF10, respectively (Figure 4). The complete matrix
of all samples is stored in Comma Separated Value (CSV)
format on the FTP server and in the local document root.
The total matrix can be visualized by importing the table
in the statistical package Spotfire. R's Wilcoxon-Mann-
Whitney rank sum test is performed for each matrix pep-
tide, based on the numbers of peptide mass occurrences
per sample in different groups. The Wilcoxon-Mann-
Whitney test discriminates the peptide masses between
the groups with a probability value (p-value). The fre-
quency distribution of the calculated p-values of the pep-
tide masses in the matrix is presented in a histogram. A
separate Wilcoxon-Mann-Whitney GUI generates this his-
togram and creates a list of the masses with corresponding
p-values. In this screen, the test can be performed on
matrices generated in different experiments and between
different groups. The results of the Wilcoxon-Mann-Whit-
ney rank sum test on a matrix are stored in a file with CSV
format. The p-values of all peptide masses, as well positive
(+) as negative (-) expressed between the groups are listed
in this file. The file is stored on the FTP server and in the
local document directory. Examples of these p-value list-
ings are given for the breast cancer with LM group against
the control group in Figure 5, and for the prostate cancer
group in end stage disease against another control group
in Figure 6. Peptide masses with the lowest p-values < 0.01
are used to search in the Human MSDB database for pro-
teins based on calculated peptide masses, using MASCOT
or are selected for MS/MS sequencing options in the mass
spectrometer.
Calibration constants
A small storage size of the files on the FTP server is guar-
antied, due to the fid format of MS spectra, a byte array of
92000 channel intensities. The TOF, time, can be calcu-
lated from the MS channel number, i, in the fid files by
timei = DELAY + (i·DW) i = 1,2,...,92000    (1)
The values of the constants DW (dwell time) and DELAY
are stored in the acqus and acqu files, which are also trans-
Snapshot of the GUI to allocate the samples to different groupsFigure 3
Snapshot of the GUI to allocate the samples to different groups. The allocation is achieved indirectly. Both samples 
and groups are linked to the mass spectra records in the table result, which contain the spot positions in their filenames.Page 6 of 16
(page number not for citation purposes)
BMC Bioinformatics 2006, 7:403 http://www.biomedcentral.com/1471-2105/7/403ported to the FTP server. Other important values are those
of the ML1, ML2 and ML3 calibration constants in the
acqus files, which are used to calculate the peptide masses
from the TOF. Theoretically, the square root of the mass
over charge, , is proportional with the TOF, time. Therefore, the value of constant B is about 40.000 times
larger than the value of constant A, where A = ML3, B =
m
z
0 2
2
= ⋅
⎛
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Snapshot of the GUI to create one of the three matricesFigure 4
Snapshot of the GUI to create one of the three matrices. A matrix is created with the number of occurrences of 
masses in replicate spectra of different samples, a binary table with number of occurrences of masses above a specific thresh-
old, and a matrix with the mean intensity of the present peaks in the mass spectra replicates. A small preview part of an exam-
ple matrix with a total of 1949 peptide masses and 111 samples, with the number of occurrences of masses in replicate spectra 
of the samples is presented at the bottom of the GUI.Page 7 of 16
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charge is
Peak finding
A peak list consists of mass over charge (m/z), channel
number i, and intensity. It is constructed from the data in
the raw fid files. A histogram of the number of channels
with a specific intensity can be constructed. The integral
under the distribution curve represents the amount of
92000 instrument channels. From this distribution curve,
the R quantile function calculates an intensity threshold,
where the probability is 98 % to find channels with a
lower intensity. The effect of changing R quantile percent-
ages between 97 and 99 % in the create matrix GUI (Fig-
ure 4) is examined. The MS peaks are expected to be in the
channels numbers, i, with intensity higher than this
threshold, namely in the range of the 3 % highest intensi-
ties. The peak finding algorithm determines the highest
channel intensity within a certain mass over charge (m/z)
window, for example 0.5 Da at both sides. A second con-
dition is that this local maximum intensity must be above
the quantile threshold intensity. Noise spectra do not con-
tain real peaks with a high intensity flanks. As a conse-
quence, many noise peaks are above the quantile
threshold. Peak lists with too many peak masses above an
arbitrary number of 450 fall off, because a large part of
these peak positions are probably noise peaks.
Internal calibration
Internal calibration is necessary to align all the spectra in
the matrix. There are several methods reported to align
mass spectra datasets. The alignment algorithms of Wong
et al. [18] and Jeffries [19] have in common that they use
special reference masses or peaks between the spectra.
Wong et al. [18] have developed an algorithm written in
C++ where spectral data points are added or deleted in
regions with a low intensity, in order to a shift peaks. This
algorithm has a slight effect on the shape of the peaks.
However, the signals in MS are presented by peaks and not
10
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Report of the Wilcoxon-Mann-Whitney p-values of the control group and the breast cancer with LM groupFigu e 5
Report of the Wilcoxon-Mann-Whitney p-values of the control group and the breast cancer with LM group. An 
example of a detailed report of the Wilcoxon-Mann-Whitney p-values of the differentially expressed peptides. The report is 
stored on the FTP server, as well in the local document directory on the client workstation. The data are stored in a file with 
Comma Separated Value (CSV) format, which can be imported in Microsoft Excel™. The p-values of all peptide masses, as well 
positive (+) as negative (-) expressed between the groups are sorted in order of ascending p-values with the most significant 
discriminating peptide masses on top, with the lowest p-value. Negative (-) expressed means in this case that the mean pep-
tides occurrences in the breast cancer with LM group are larger than in the control group.Page 8 of 16
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peaks lists generated from mass spectra. He uses R's
smooth spline function to correct measured masses with
help of reference calibrate masses. A smooth spline func-
tion, fλ, is drawn through the ratio of measured over real
mass on the y-axis against the measured mass of the cali-
brate peaks on the x-axis, which results in a factor close to
1. Division of the measured masses by the calculated func-
tion fλ; interpolates all data points. Theoretically, a cubic
spline function needs to pass through all of the calibrate
data points. This results in a lot of curvature. A smooth
spline is a compromise; where the function may deviate
from calibrate data points within a certain limit, due to a
factor λ, which diminishes the amount of slope. The
amount of slope is expressed by the integrating the square
of the second derivative of the spline function [19].
Another alignment algorithm assumes no knowledge of
peaks in common [20,21]. This method considers the
shape of the spectra, and aims to minimize the phase dif-
ferences between the spectra. This process is named
dynamic time warping. It is however easier to calibrate the
channel numbers of the MALDI-TOF equipment against
known masses, since the square root of mass over charge
is theoretically proportional to the time. This dependency
can be fit with a polynomial function. The masses in the
peak list are internally calibrated, using the at least 4 of the
5 omnipresent albumin masses. The channel numbers in
the peak list, with corresponding masses, which are the
closest with a window of 0.5 Da to one of the albumin
masses, are determined. Peak lists without the required
number of albumin masses fall off. The channel numbers,
i, and corresponding albumin masses, , are fit in a sec-
ond-degree polynomial function
The coefficients, a [0], a[1], and a[2] are calculated with
R's linear model (lm) function where y = , x = i, and a
is the array of a [0], a[1], and a[2]
ft3 ← lm(y ~I(x^2) + x)    (5)
a ← coeff (ft3)    (6)
All peptide masses in the peak list are recalculated, using
these coefficients and the polynomial function.
Data reduction
Last step is the creation of the profile matrix, which con-
sists of peptide masses in all spectra of the samples in the
m
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m
z
a i a i a
i
= [ ] ⋅ + [ ] ⋅ + [ ] ( )1 2 0 42
m
zi
Report of the Wilcoxon-Mann-Whitney p-values the control group and the end stage prostate cancer groupFigu e 6
Report of the Wilcoxon-Mann-Whitney p-values the control group and the end stage prostate cancer group. 
An example of a detailed report of the Wilcoxon-Mann-Whitney p-values of the differentially expressed peptides. The report 
is stored on the FTP server, as well in the local document directory on the client workstation.Page 9 of 16
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samples in the rows. The matrix is the input file for the
Wilcox-Mann-Whitney test, but can also be input for
other statistical packages, like Spotfire. The matrix is
stored on the FTP server, as well as in the local document
directory. Figure 7 schematically shows the clustering of
two spectra in the matrix. Within a mass window of 0.5
Da at both sides of a peptide mass in the first spectrum,
the occurrence of at least one peptide mass in the second
spectrum is investigated, closest in distance to the peak in
the first spectrum. If that is the case, the average mass of
both peptide masses is calculated (dashed line in Figure
7), and the number of occurrences in both spectra
summed. For each mass spectrum, only one peptide
occurrence, 1 or 0, is summed for each mass window. If a
peptide mass is present in the second spectrum, but not in
the first spectrum it is added to the mass list. The average
intensity of the present masses is also stored in a separate
matrix. The clustering continues iteratively though all
spectra of the samples in the matrix. All averages are cal-
culated at the end of the clustering routine. In the data-
base application, the clustering of selected spectra is in the
order of ascending groupid, ascending sampleid, and
ascending resultid values in records of the table result,
which are pointers to the files on the FTP server. The effect
of reversed clustering is studied by changing the order in
descending groupid, descending sampleid, and descending
resultid values of the table result.
Results
The first data set with CSF mass spectra was previously
reported by Dekker and co-workers [3,4]. The optimal
quantile percentage of 98% in peptide profiling [3,4] is
confirmed in our database application. At a relative low
quantile percentage of 97%, close to the noise level, many
spectra are rejected due to a large amount of noise peaks
with numbers above the threshold of 450. This result in a
relatively low number of matrix samples due to too low
replicate numbers. The matrix consists of peptide masses
present in all spectra of the samples in columns against
the occurrences in replicate spectra of the samples in the
rows. At a high quantile percentage of 99%, internal cali-
bration is not possible for many spectra, because albumin
peak intensities are below the quantile threshold. Again
many samples have too low replicate numbers, resulting
in a relatively low number of matrix samples. An effect of
reversed selection of replicate spectra of samples is
expected and measured, when replicate numbers are
smaller than the (dataset dependent) value of 7, since the
replicate spectra contribute a different part of the total
Data reductionFigur  7
Data reduction. Data reduction by finding peak maxima and combining the measured peptide masses in the different spectra. 
Occurrences of masses with a window of 0.5 Da are summed, and the average value of the mass is calculated (dashed line). The 
occurrence of only one peptide in the second spectrum is summed in the mass window of the first spectrum. The second peak 
of spectrum 2 and not the first one is combined with the first peak of spectrum 1, since it has the closest distance in mass (Da) 
with the first peak of spectrum 1. Not previously registered masses in the first spectrum are added to the list. The clustering 
continues iteratively through all mass spectra of the samples in the matrix.Page 10 of 16
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value of 7, no effect of changing the order of selecting rep-
licates is expected. No effect of reversed clustering of the
selected spectra is measured on the number of samples
and peptide masses in the matrix (Figure 7). The Wil-
coxon-Mann-Whitney test is best performed on a matrix
with the most samples and peptide masses, generated at a
quantile percentage of 98%. Figures 8, 9, 10 show exam-
ples of the distributions of the frequency of all the pep-
tides in the matrix as a function of the Wilcoxon-Mann-
Whitney p-value, a) of the control group versus the group
with breast cancer (Figure 8), b) of the control group ver-
sus the group of breast cancer with LM (Figure 9), and c)
of another control group versus end stage prostate (Figure
10). There are some differences in shape of the Wilcoxon-
Mann-Whitney probability p-value frequency distribu-
tions presented in Figures 8, 9, 10 with those presented
earlier [3], since we used a mass range of 800 to 4000 (pre-
viously 300–3000 [3]) and we did not leave out peptide
masses, which are measured in less than 5 % of the spec-
tra, which results in sharp peaks at p-values of 0.20, 0.28,
and 0.38. The frequency histograms of the Wilcoxon-
Mann-Whitney p-values of both comparisons a) and b) of
the breast cancer patients clearly display a different shape.
All peptides are equally distributed over all p-values for
the control group versus the group with breast cancer in
Figure 8. A line is drawn in the plot, which represents the
frequency of p-values of peptides after a 1000 times
scrambling of the samples over the two groups in the
matrix. This random distribution is about equal to the
measured pattern of the control group versus the group
with breast cancer. Some sharp frequency peaks are calcu-
lated at p-values of 0.20, 0.28, and 0.38. The p-values of
0.28 and 0.38 are calculated when a peptide mass is meas-
ured once in a spectrum of one sample in the control
group (smallest group) or in the group with breast cancer
(largest group) of the matrix. This occurs quite often, as
can be seen by the relatively high frequency in the histo-
gram at these p-values. Randomization of the sample with
this single peptide peak over the groups hardly changes
the frequency of these p-values. This is confirmed by the
Histogram of the number of peptide masses with Wilcoxon-Mann-Whitney probability p-values of the control versus the breast cancer with LM groupFigure 9
Histogram of the number of peptide masses with 
Wilcoxon-Mann-Whitney probability p-values of the 
control versus the breast cancer with LM group. All 
1949 identified peptide masses in the matrix are presented as 
a function of the Wilcoxon-Mann-Whitney probability p-
value. The white bars represent the frequency of the peptide 
masses with a p-value in the control group, while the black 
bars represent the frequency of the peptide masses with a p-
value in the breast cancer with LM group. 152 peptide 
masses are significantly differentially expressed in the breast 
cancer with LM group (p-value less than 0.01, ranging from 
1.1 * 10-6 to 9.8 * 10-3).
Histogram of the number of peptide masses with Wilcoxon-Mann-Whitney probability p-values of the control versus breast cancer groupFigure 8
Histogram of the number of peptide masses with 
Wilcoxon-Mann-Whitney probability p-values of the 
control versus breast cancer group. All 1949 identified 
peptide masses in the matrix are presented as a function of 
the Wilcoxon-Mann-Whitney probability p-value. The Wil-
coxon-Mann-Whitney p-value is calculated for each peptide 
mass based on its occurrences in replicate samples in each 
group. The white bars represent the frequency of the pep-
tide masses with a p-value in the control group, while the 
black bars represent the frequency of the peptide masses 
with a p-value in the breast cancer group.Page 11 of 16
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8). The p-value of 0.20 corresponds to peptide masses
found in total two times in two different samples in one
group. As expected, by randomization, the frequency of
this p-value decreases in favor of the p-values of 0.28 or
0.38, since the two samples can be allocated to two
groups. The solid line displays a small decrease of the fre-
quency at p-values 0.20 and larger increase of the fre-
quency at p-value 0.28. The frequency of p-values shows a
small decline below 0.01, which means that there is a
small amount of differentially expressed peptides. The
shape of the frequency distribution of Wilcoxon-Mann-
Whitney p-values for the peptide masses is remarkably dif-
ferent when we compare the CSF peptide profiles from the
control group with the profiles from the group of breast
cancer with LM (Figure 9). Again sharp peaks in frequency
are observed at p-values of 0.20 and 0.38, and a smaller
peak at 0.28. However, the histogram shows also sharp
increase of the frequency of peptides with p-values below
0.01. This indicates that there are significantly differen-
tially expressed peptides present in the CSF from the LM
breast cancer patients. A total of 1949 peptide masses are
identified in the 45 control and 54 LM breast cancer sam-
ples. Of these, 152 peptide masses have a p-value < 0.01,
ranging from 1.1 * 10-6 to 9.8 * 10-3. A similar pattern of
the Wilcoxon-Mann-Whitney p-value distribution is seen
in Figure 10, when the end stage prostate cancer samples
are compared with those of the control group. Again three
maxima are observed at p-values of 0.23 for in total two
peptide mass occurrences in separate samples in one
group, 0.27 for one occurrence in one sample in the
smaller metastasis group, and 0.42 for one occurrence in
one sample of the larger control group. Again an increas-
ing number of peptide masses with p-values < 0.01 are
seen in the histogram. A total of 1354 peptide masses are
identified in the 20 control samples and 15 end stage
prostate cancer samples. Of these, 128 peptide masses
have a p-value < 0.01, ranging from 2.7 * 10-7 to 9.9 * 10-3.
Discussion
The database application can clearly distinguish the
MALDI-TOF peptide profiles between different patient
and control groups. It can determine differences in the fre-
quency and intensities of peptide masses in spectra from
both groups. A strong feature of the here described archi-
tecture is that it can process different MS file formats, such
as peak lists, MALDI-TOF and FT-ICR binary files from
various manufactures in the same manner. More impor-
tant are speed and memory usage by the client worksta-
tion. Peptide profile matrices have to be created in
reasonable time. When dealing with large quantity of
data, the Java application will easily run into out of mem-
ory errors with default settings of the JVM. Very important
to use limit and offset strategies in MySQL queries to fetch
no more than a buffered amount of 5000 table records
each time when displaying them in the GUI. A specific
MALDI-TOF MS matrix of 111 samples and 1949 masses
(Figure 4) has 216339 matrix fields and a CSV file size of
444 Kbytes. Three matrices, peptide mass occurrences,
intensity, and binary of this size can be simultaneously
built in the Java Virtual Machine's (JVM) allocated mem-
ory. However, a typical FTMS matrix with 374 samples
and 10651 discriminated masses has an 18 times larger
number of 3983474 matrix fields and an 18 times larger
CSV file size of 7.9 Mbytes. It is impossible to build three
matrices of these size simultaneously in the Java's mem-
ory space. These files have to be built in the user docu-
ment root as a FileOutputStream and transported to the
FTP server.
Architecture
It is also possible to use the SJava package [22] to set up
an interface between Java and the statistical software pack-
age R. It can be used to invoke Java methods and create
Java objects by R commands. This is, however, the oppo-
site of our approach, where R is called from Java. Another
Histogram of the number of peptide masses with Wilcoxon-Mann-Whitney probability p-values of the control versus the end stage prostate c nc  grouFigure 10
Histogram of the number of peptide masses with 
Wilcoxon-Mann-Whitney probability p-values of the 
control versus the end stage prostate cancer group. 
All 1354 identified peptide masses in the matrix are pre-
sented as a function of the Wilcoxon-Mann-Whitney proba-
bility p-value. The white bars represent the frequency of 
peptide masses in the control group with a specific p-value, 
while the black bars represent the frequency of peptide 
masses with a p-value in the prostate cancer in end stage dis-
ease group. 128 peptide masses have a p value of less than 
0.01, ranging from 2.7 * 10-7 to 9.9 * 10-3.Page 12 of 16
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Protocol-Internet Protocol) connection, using the service
Rserve™. A disadvantage of using this method is that the
Rserve has to be started explicitly by the operating system
out of the Java application before running any R script
from Java. It would be possible to make additional java
classes for statistical routines, such as the Wilcoxon-
Mann-Whitney test. Indeed for this one test it would be
more logical to add it directly to the Java code. However,
the usage of R goes beyond just the Wilcoxon-Mann-Whit-
ney test, which is not being claimed to be the full analysis.
The Wilcoxon-Mann-Whitney test is an example of a uni-
variate test that is an important first step. In R, it is possi-
ble to switch to other univariate tests and most
importantly multivariate analysis, such as hierarchical
clustering in two dimensions (where Spotfire™ fails with
very big matrices). In addition, R can be used for the peak
finding algorithms (quantile calculations, baseline and
noise level determination, etc.) which have the advantage
that these algorithms are well tested and optimized for
speed. The architecture allows the analysis to be extended
to clustering, the building of multivariate classifiers, etc.
(techniques we have already used in our previous paper
[3]). This will be an important point to focus on in the
future. A reason to implement a 2-tier architecture, thick
client and database server, is to have an attractive Java GUI
than less advanced interface and Java script in a web
browser. It's possible to monitor preprocessing of the MS
spectra with a progress bar. Another possibility is to con-
vert instrument specific file types to uniform mzXML file
format and display spectra with a Java mzXML viewer
[29]. A 3-tier architecture with presentation layer (web-
browser), business logic provided by an application
server, and a database server is more difficult to imple-
ment. For example, the file interface of Java with the soft-
ware package R is more difficult than in the 2-tier
architecture. In the 2-tier situation every user has its own
file repository on the local machine. In a 3-tier, special
precautions have to be taken to prevent time-out errors
and performance issues, applying distributed computing
in a grid. For example, an FT-ICR MS peptide profile
matrix of 10651 discriminated masses and 374 samples
with at least 3 peptide occurrences per mass has a size of
7887 Kbytes and is produced in no less time than 12 h.
Pre-processing
More advanced techniques such as Fourier transform ion
cyclotron resonance (FT-ICR) MS and offline nano LC-
MALDI (Liquid Chromatography) in combination with
FT-ICR measure accurate masses in the 0.5 to 1 ppm
range. Furthermore, the higher resolution of FT-ICR MS
prevents the clustering of peaks of different peptides.
These techniques allow the identification of proteins from
peptide masses by either peptide mapping or peptide
sequencing. The database application can be adapted to
handle the mass spectra of these experiments due to its
modular architecture. The type of equipment, in combi-
nation with type of imported spectra will determine the
handling of raw data, such as calibration and peak finding
algorithms. In order to transform the spectra from the
time domain to the frequency domain [23], an extra Fast
Fourier Transformation (FFT) step to handle raw data of
FT-ICR experiments is at present under construction. The
peptide masses can subsequently be calculated from the
cyclotron frequency. It is also possible to apply a de-iso-
tope algorithm on the peptide masses due to the higher
resolution and mass accuracy of FT-ICR. Peak centroiding
will be implemented, which calculates the real mass of the
peak maximum, weighted by the intensity of the points
surrounding the local maximum[24].
Database
The database is stripped to its essentials and contains all
the necessary fields for preprocessing while most of the
input parameters are stored in the matrices filenames. For
example, the database design does not contain an authen-
tication database for encrypted password storage and
management of user accounts. Other tables that are not
included are audit trail and action logging tables found in
modern LIMS. Details of the database design are pre-
sented in the proteomics.txt create table script (added as a
supplementary file). The database tables contain the nec-
essary (on delete) table triggers, which ensure database
integrity. The database design allows the comparison of
large quantity of mass spectra. The table result offers the
possibility to store retention times and to group sequen-
tial mass spectra from one sample in a LC-MS experiment.
An improved peak finding algorithm based on signal to
noise levels is under construction [25]. An extra table with
calculated peptide masses of expected proteins from MS-
MS experiments can be added to the database, which will
make a direct analysis of differentially expressed proteins
possible.
FTP
The use of an ordinary FTP server in a university environ-
ment is a security risk that cannot be underestimated. On
the other hand, FTP is a standard that is accepted and
widely accessible across every network and operating sys-
tem. First of all, precautions have to be taken with setup
and configuration of an FTP server as described e.g. by Ray
Zadjmool [26]. The architecture disables anonymous
access. However it not possible to register user accounts
and connection is made by one root account. Users and IP
addresses have to be logged as well as success of fail of
account logon events. Account should be locked after sev-
eral failed login attempts. Access to the FTP directory
should be regulated using access control list (ACL) restric-
tions across Windows NT File System (NTFS) permissions.
Disk quota should be enabled to limit the amount of diskPage 13 of 16
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place for hackers. IP address restriction should be set
equal to the range of Hospital or University IP addresses.
The user passwords must meet complexity requirements.
However, FTP servers can only handle usernames and
passwords in plain text, which can easily be intercepted by
password sniffers. Sensitive data and login information
can be encrypted for total security using FTPS or SFTP,
which solves the problem of insecure FTP. FTPS (FTP over
SSL) uses a Secure Socket program Layer (SSL) located
between the FTP and Transport Control Protocol (TCP)
layers. FTPS has the encryption capabilities of SSL with the
advanced features of FTP. Unfortunately, Enterprise Dis-
tributed Technologies [8] provides only a commercial Java
library, which supports FTPS and SFTP. An open source
Java secure shell version 2 (SSH-2) library, jsch-0.1.28.jar,
that supports SFTP (FTP over SSH) is provided by JCraft
[27].
Bonferroni
In the Bonferroni approach to n independent tests, the
overall change β to make an error of type 1 is the product
of the individual errors β'.
β = β'1 * β'2 * β'3 ......... β'n = (1-p')n = 1 - p    (7)
According to the binominal theorem, for small values of
p'
These equations show that the overall p-value threshold,
p, should be divided by n to obtain the significance level,
p' of the individual tests.
In both the CSF and prostate cancer datasets some tests
satisfy the Bonferroni multiple test approach, for example
1.1 * 10–6 < 0.01/1949 and 2.7 * 10–7 < 0.01/1354. The
Bonferroni approach may not be ideally suited for this
type of data as the presence of individual peptide peaks
may be correlated, since they can be isotopes of the same
peptide or peptides from the same protein. Rather than
lowering the p-value threshold in a Bonferroni approach,
the complete p-value distribution (and a randomization
method to check the expected distribution) is shown. The
numbers are explicitly supplied, because the plot does not
specify the exact p-values lower than 0.01.
Conclusion
A new software architecture is presented which can ana-
lyze high throughput MS data from MALDI-TOF MS
measurements in a efficient way. Results of the analysis
are stored in a centralized relational database and FTP
server. Meta data of the experiment and samples can be
stored as well, and can be used to link the results to clini-
cal data or data from other types of experiments. The data-
base application generates a matrix with the frequency of
masses in replicate spectra from different samples, a
binary table with the frequency of masses above a specific
threshold, and a matrix with the mean intensity of the
present peaks in the mass spectra replicates. The matrix,
which is stored on the FTP server and in the local docu-
ment directory, can be imported in statistical packages or
in (commercial) analysis software such as Spotfire. Statis-
tical analysis of two test datasets by the Wilcoxon-Mann-
Whitney test in R clearly distinguishes the peptide-profiles
of patient body fluids from those of controls. Finally, the
modular architecture of the application makes it possible
to also handle data from FT-ICR experiments.
Availability and requirements
Java source code, create table script and installation
instructions are added as additional files [see Additional
file 1, 2, 3, 4, 5 and 6].
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